Weiss Multi Strategy Advisers LLC Amicus Therapeutics, Inc. Transaction History
Weiss Multi Strategy Advisers LLC
- $0
- Q1 2024
A detailed history of Weiss Multi Strategy Advisers LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Weiss Multi Strategy Advisers LLC holds 10,000 shares of FOLD stock, worth $99,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$99,600% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding FOLD
# of Institutions
313Shares Held
314MCall Options Held
516KPut Options Held
833K-
Vanguard Group Inc Valley Forge, PA28.8MShares$287 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$279 Million7.83% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$243 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA24MShares$239 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$231 Million3.72% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.79B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...